Our researchers are fighting the coronavirus pandemic with innovative approaches. With your donation you can support them in developing drugs and vaccines against the virus or in deciphering the mechanisms of disease development and progression. Here you can find out all about donation opportunities.
Learn more about how the HZI, with its translational focus, will help to facilitate a faster and more targeted approach when it comes to fighting and preventing existing, emerging or recurring infectious diseases.
Here you can find out more about the scientific results of the HZI in the research topics ”Bacterial and Viral Pathogens”, “Immune Response and Interventions” and “Anti-Infectives”.
Around 900 employees in research, administration and infrastructure, and about 220 visiting scientists from 40 different countries are employed at the Helmholtz Centre for Infection Research. To ensure top quality research we need top quality employees. Your creativity and innovative capabilities are the basis for the long-term success of our work. That's why we undertake a great deal to attract the best people to us. Learn more about this.
We communicate also through social media. Join our Facebook page, follow us on Twitter or subscribe to our YouTube-Channel.
The coronaviruses are a family of viruses that includes a series of very different pathogens. These viruses usually infect mammals, rodents, and birds, but only few coronaviruses adapted to humans. They did this with great success: About one third of all typical "common colds" and some cases of diarrhoea as well are caused by these RNA Viruses, which are the largest of their kind. We have compiled more information about the coronaviruses for you.
With the pathogen SARS-CoV-2, a novel virus that can cause respiratory diseases and pneumonia has been spreading worldwide since the end of 2019. Here we will keep you informed about current developments in research and provide answers to the most important questions.
HomePressVideos & PodcastsVideos
Results 1 to 9 of total 52
Vector-based vaccines saw their public breakthrough with the development of several SARS-CoV-2 vaccines. With this technology, harmless helper viruses transport the genetic code for an antigen into host cells. The host cells produce the antigen and present it on their surface, which triggers an immune response. While the SARS-CoV-2 vector vaccines are based on a modified version…
The grants of the European Research Council (ERC) are among the most important and prestigious funding instruments in science. Accordingly, there is great joy about receiving the award – not only in Würzburg, but also in Braunschweig: HIRI is a joint venture of the Helmholtz Centre for Infection Research (HZI) there and the Julius Maximilians University (JMU) in Würzburg.
The hospital germ Pseudomonas aeruginosa causes a variety of infectious diseases: from pneumonia to wound, eye and urinary tract infections to sepsis. Pneumonia caused by P. aeruginosa poses a particular threat to cystic fibrosis and Covid-19 patients during artificial respiration. The threat posed by this germ is exacerbated by the fact that variants are increasingly becoming…
Infections with the encephalomyocarditis virus (EMCV) affect a variety of mammals such as pigs and chimpanzees. However, humans can also become infected, resulting in fever and inflammatory disease. Like other cardioviruses – or like the highly infectious coronavirus SARS-CoV-2 – EMCV is an RNA virus: its genetic material consists of ribonucleic acid (RNA). Since viruses do not have…
The SARS-CoV-2 coronavirus carries different surface proteins, where Spike is the most prominent example and a crucial component of vaccine formulations. The Spike of the new Omicron variant has been investigated by a team of researchers from the Braunschweig University of Technology together with partners from the EU consortium ATAC (Antibody Therapy Against Corona), the Helmholtz…